Author

Shunsuke Nojiri

Observed names: Nojiri, Shunsuke, S Nojiri, S. Nojiri, S., Nojiri

Observed institutions: Thomas Jefferson University, Nagoya City University, Nagoya City University Hospital, Inabe General Hospital, Nagoya University, Niigata University

OpenAlex ID: A5020203707

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial

2019 · Masatoshi Kudo, Kazuomi Ueshima, et al. · Gut · 724

PDF

Gut Dysbiosis Associated With Hepatitis C Virus Infection

2018 · Takako Inoue, Jiro Nakayama, et al. · Clinical Infectious Diseases · 183

PDF

Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma

2022 · Masatoshi Kudo, Kazuomi Ueshima, et al. · Liver Cancer · 147

Distribution of Hepatitis B Virus Genotypes among Patients with Chronic Infection in Japan Shifting toward an Increase of Genotype A

2009 · Kentaro Matsuura, Yasuhito Tanaka, et al. · Journal of Clinical Microbiology · 138

Mesenchymal stem cell therapies for liver cirrhosis: MSCs as “conducting cells” for improvement of liver fibrosis and regeneration

2019 · Atsunori Tsuchiya, Suguru Takeuchi, et al. · Inflammation and Regeneration · 114

PDF

A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial

2023 · Masatoshi Kudo, Kazuomi Ueshima, et al. · Liver Cancer · 112

Albumin Suppresses Human Hepatocellular Carcinoma Proliferation and the Cell Cycle

2014 · Shunsuke Nojiri, Takashi Joh · International Journal of Molecular Sciences · 104

PDF

Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis

2021 · Suguru Takeuchi, Atsunori Tsuchiya, et al. · npj Regenerative Medicine · 91

PDF

Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles

2020 · Takayuki Watanabe, Atsunori Tsuchiya, et al. · Regenerative Therapy · 87

PDF

Application of a Newly Developed High-Sensitivity HBsAg Chemiluminescent Enzyme Immunoassay for Hepatitis B Patients with HBsAg Seroclearance

2013 · Noboru Shinkai, Kentaro Matsuura, et al. · Journal of Clinical Microbiology · 74

Small bile duct involvement in IgG4-related sclerosing cholangitis: liver biopsy and cholangiography correlation

2010 · Itaru Naitoh, Yoh Zen, et al. · Journal of Gastroenterology · 74

ATBF1 enhances the suppression of STAT3 signaling by interaction with PIAS3

2003 · Shunsuke Nojiri, Takashi Joh, et al. · Biochemical and Biophysical Research Communications · 56

Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: A randomized trial

2016 · Shunsuke Nojiri, Kei Fujiwara, et al. · Nutrition · 54

Efficacy of daclatasvir/asunaprevir according to resistance-associated variants in chronic hepatitis C with genotype 1

2016 · Etsuko Iio, Noritomo Shimada, et al. · Journal of Gastroenterology · 45

Mesenchymal stem cells cultured under hypoxic conditions had a greater therapeutic effect on mice with liver cirrhosis compared to those cultured under normal oxygen conditions

2019 · Yuichi Kojima, Atsunori Tsuchiya, et al. · Regenerative Therapy · 43

PDF

Impaired gastric motility and its relationship to reflux symptoms in patients with nonerosive gastroesophageal reflux disease

2009 · Takeshi Kamiya, Hiroshi Adachi, et al. · Journal of Gastroenterology · 41

Randomized, open label, multicenter, phase II trial comparing transarterial chemoembolization (TACE) plus sorafenib with TACE alone in patients with hepatocellular carcinoma (HCC): TACTICS trial.

2018 · Masatoshi Kudo, Kazuomi Ueshima, et al. · Journal of Clinical Oncology · 39

Roles of Tissue Transglutaminase in Ethanol-induced Inhibition of Hepatocyte Proliferation and α1-Adrenergic Signal Transduction

2000 · Jian Wu, Shu-Ling Liu, et al. · Journal of Biological Chemistry · 39

Changes in serum lipid profiles caused by three regimens of interferon‐free direct‐acting antivirals for patients infected with hepatitis C virus

2017 · Takako Inoue, Takaaki Goto, et al. · Hepatology Research · 37

PDF

Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy

2017 · Etsuko Iio, Noritomo Shimada, et al. · Hepatology Research · 37

Case–control study for the identification of virological factors associated with fulminant hepatitis B

2009 · Atsunori Kusakabe, Yasuhito Tanaka, et al. · Hepatology Research · 37

Pitavastatin inhibits hepatic steatosis and fibrosis in non‐alcoholic steatohepatitis model rats

2011 · Tomokatsu Miyaki, Shunsuke Nojiri, et al. · Hepatology Research · 35

Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice

2021 · Shunsuke Nojiri, Atsunori Tsuchiya, et al. · Inflammation and Regeneration · 29

PDF

Abbott RealTime Hepatitis C Virus (HCV) and Roche Cobas AmpliPrep/Cobas TaqMan HCV Assays for Prediction of Sustained Virological Response to Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients

2008 · Kentaro Matsuura, Yasuhito Tanaka, et al. · Journal of Clinical Microbiology · 26

A population-based cohort study for the risk factors of HCC among hepatitis B virus mono-infected subjects in Japan

2010 · Atsunori Kusakabe, Yasuhito Tanaka, et al. · Journal of Gastroenterology · 25

Works count: 99

Citation count: 2,839

H-index: 25

I10-index: 43